If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
ARX-METHOTREXATE 10 methotrexate 10 mg tablet blister pack AUST R: 365590Active ingredients:
methotrexate
Dosage form:
Tablet
Sponsor:
Cipla Australia Pty Ltd
Phone:
0396964413
|
From
24 Oct 2024
to
20 Dec 2024
|
Shortage status:
Anticipated
Availability:
Available
Reason:
Manufacturing
Management action:
Alternative generic products are available.
|
DBL METHOTREXATE 5mg/2mL injection vial AUST R: 16313Active ingredients:
methotrexate
Dosage form:
Injection, solution
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800-675-229
|
From
29 May 2024
to
03 Jul 2024
|
Shortage status:
Resolved
Availability:
Available
Reason:
Manufacturing
|
METHOTREXATE ACCORD methotrexate 1000mg/10mL injection vial AUST R: 213737Active ingredients:
methotrexate
Dosage form:
Injection, solution
Sponsor:
Accord Healthcare Pty Ltd
Phone:
1800 222 673
|
From
23 Apr 2024
to
19 Jun 2024
|
Shortage status:
Resolved
Availability:
Available
Reason:
Manufacturing
|
METHOBLASTIN methotrexate 10mg tablet bottle AUST R: 15417Active ingredients:
methotrexate
Dosage form:
Tablet, uncoated
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800-675-229
|
Deletion from market:
01 Nov 2024
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Product will be replaced by METHOBLASTIN methotrexate (as sodium) 10 mg tablet blister pack ARTG 410933.
|
Pfizer (Australia) METHOTREXATE 1000mg/10mL injection BP vial AUST R: 10778Active ingredients:
methotrexate
Dosage form:
Injection, solution
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800-675-229
|
Deletion from market:
01 Dec 2023
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
|
Pfizer (Australia) METHOTREXATE 50mg/2mL injection BP AUST R: 10777Active ingredients:
methotrexate
Dosage form:
Injection, solution
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800-675-229
|
Deletion from market:
01 Dec 2024
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Other generic by same sponsor available -
DBL METHOTREXATE 50mg/2mL injection BP vial (ARTG 16314)
|